Results 251 to 260 of about 157,653 (303)
Some of the next articles are maybe not open access.
Annual Review of Medicine, 2005
The development of new anticoagulants is expanding the list of drugs that can be used to prevent and treat venous and arterial thrombosis. New parenteral anticoagulants have been developed to overcome the limitations of heparin and low-molecular-weight heparin, whereas novel orally active anticoagulants have been designed to provide more streamlined ...
Lori-Ann, Linkins, Jeffrey I, Weitz
openaire +2 more sources
The development of new anticoagulants is expanding the list of drugs that can be used to prevent and treat venous and arterial thrombosis. New parenteral anticoagulants have been developed to overcome the limitations of heparin and low-molecular-weight heparin, whereas novel orally active anticoagulants have been designed to provide more streamlined ...
Lori-Ann, Linkins, Jeffrey I, Weitz
openaire +2 more sources
Reversing Anticoagulant Therapy
Current Drug Discovery Technologies, 2012For more than 50 years, heparin(s) and warfarin have been the most important anticoagulant agents, and clinicians are accustomed to their specific antidotes (protamine sulfate and vitamin K/plasma [or factor concentrates], respectively). Recently, there has been an explosion of novel anticoagulant development: ideally, these newer agents should have ...
Shari, Ghanny +2 more
openaire +2 more sources
Archives of Internal Medicine, 1993
Congratulations on a good broad overview of the history and current status of oral anticoagulant drugs. 1 In this regard, I would like to mention briefly some recent data that may be of interest to readers. Kant and colleagues 2 have described the occurrence of warfarin-induced skin necrosis in relationship to peritoneal dialysis—associated loss of ...
openaire +2 more sources
Congratulations on a good broad overview of the history and current status of oral anticoagulant drugs. 1 In this regard, I would like to mention briefly some recent data that may be of interest to readers. Kant and colleagues 2 have described the occurrence of warfarin-induced skin necrosis in relationship to peritoneal dialysis—associated loss of ...
openaire +2 more sources
Current Opinion in Hematology, 1996
Oral anticoagulant therapy is effective antithrombotic treatment for several indications. The results of prothrombin time monitoring should be reported as the International Normalized Ratio (INR). An INR of 2 to 3 is the recommended therapeutic range for all indications except for the prevention of systemic embolism in patients with mechanical heart ...
openaire +2 more sources
Oral anticoagulant therapy is effective antithrombotic treatment for several indications. The results of prothrombin time monitoring should be reported as the International Normalized Ratio (INR). An INR of 2 to 3 is the recommended therapeutic range for all indications except for the prevention of systemic embolism in patients with mechanical heart ...
openaire +2 more sources
Hospital Practice, 1983
More realistic expectations regarding the efficacy of oral anticoagulants in treating thromboembolic disorders have led to more rational use of the coumarins. Their mode of action and its bearing on clinical application are discussed.
openaire +2 more sources
More realistic expectations regarding the efficacy of oral anticoagulants in treating thromboembolic disorders have led to more rational use of the coumarins. Their mode of action and its bearing on clinical application are discussed.
openaire +2 more sources
Warfarin anticoagulant therapy
British Dental Journal, 1984L, Poller, D A, Taberner
openaire +4 more sources
Radiation therapy‐associated toxicity: Etiology, management, and prevention
Ca-A Cancer Journal for Clinicians, 2021Kyle Wang
exaly